2XYF
HIV-1 Inhibitors with a Tertiary-Alcohol-containing Transition-State Mimic and various P2 and P1 prime Substituents
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | MAX II BEAMLINE I911-3 |
Synchrotron site | MAX II |
Beamline | I911-3 |
Temperature [K] | 180 |
Detector technology | CCD |
Collection date | 2008-02-13 |
Detector | MARRESEARCH |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 58.120, 85.880, 46.170 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 24.590 - 1.800 |
R-factor | 0.223 |
Rwork | 0.223 |
R-free | 0.25000 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2wl0 |
RMSD bond length | 0.006 |
RMSD bond angle | 1.200 |
Data reduction software | MOSFLM |
Data scaling software | CCP4 |
Phasing software | CNS |
Refinement software | CNS (1.1) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.700 | 1.860 |
High resolution limit [Å] | 1.800 | 1.760 |
Rmerge | 0.090 | 0.180 |
Number of reflections | 21982 | |
<I/σ(I)> | 5.4 | 4.1 |
Completeness [%] | 94.8 | 80.4 |
Redundancy | 6.7 | 3.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 5 | PROTEASE 2 MG/ML PRECIPITANT 0.7 M NACL, 100 MM MES PH 5.5 |